Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study of the Safety and Efficacy of Combination Treatment With REP 2139-Ca and Pegasys in Patients With Hepatitis B / Hepatitis D Co-infection

Trial Profile

A Study of the Safety and Efficacy of Combination Treatment With REP 2139-Ca and Pegasys in Patients With Hepatitis B / Hepatitis D Co-infection

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 14 Apr 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Peginterferon alfa-2a (Primary) ; REP 2139 (Primary)
  • Indications Hepatitis B; Hepatitis D
  • Focus Adverse reactions; Proof of concept
  • Sponsors REPLICor
  • Most Recent Events

    • 01 Apr 2019 According to a REPLICor media release, data for modeling antiviral responses from this study will be presented from the ongoing collaboration with Dr.Harel Dahari of the Loyola University Medical Center on 12th April 2019.
    • 01 Apr 2019 According to a REPLICor media release, data from this trial will be presented at the 2019 European Association for the Study of the Liver (EASL) International Liver Conference (ILC) to be held April 10th -14th, 2019 in Vienna, Austria.
    • 01 Mar 2019 According to a REPLICor media release, data from this trial alongwith trial REP401 will be presented at the The European Association for the Study of the Liver (EASL) American/ Association for the Study of Liver Disease HBV Endpoints Meeting to be held March 8th- 9th, 2019 in London, UK.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top